Annual Operating Expenses
$351.35 M
+$114.22 M+48.17%
December 31, 2023
Summary
- As of February 7, 2025, RXRX annual total operating expenses is $351.35 million, with the most recent change of +$114.22 million (+48.17%) on December 31, 2023.
- During the last 3 years, RXRX annual operating expenses has risen by +$263.32 million (+299.13%).
- RXRX annual operating expenses is now at all-time high.
Performance
RXRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$112.36 M
+$6.61 M+6.25%
September 30, 2024
Summary
- As of February 7, 2025, RXRX quarterly total operating expenses is $112.36 million, with the most recent change of +$6.61 million (+6.25%) on September 30, 2024.
- Over the past year, RXRX quarterly operating expenses has increased by +$13.69 million (+13.88%).
- RXRX quarterly operating expenses is now at all-time high.
Performance
RXRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
RXRX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +48.2% | +13.9% |
| 3 y3 years | +299.1% | +76.1% |
| 5 y5 years | +447.7% | +76.1% |
RXRX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +82.3% | at high | +110.1% |
| 5 y | 5-year | at high | +447.7% | at high | +516.8% |
| alltime | all time | at high | +447.7% | at high | +516.8% |
Recursion Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $112.36 M(+6.2%) |
| Jun 2024 | - | $105.75 M(+7.2%) |
| Mar 2024 | - | $98.67 M(-1.0%) |
| Dec 2023 | $351.35 M(+48.2%) | $99.67 M(+0.9%) |
| Sep 2023 | - | $98.78 M(+18.5%) |
| Jun 2023 | - | $83.35 M(+19.8%) |
| Mar 2023 | - | $69.55 M(+9.0%) |
| Dec 2022 | $237.13 M | $63.82 M(+6.0%) |
| Sep 2022 | - | $60.22 M(+1.0%) |
| Jun 2022 | - | $59.62 M(+11.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $53.48 M(-20.7%) |
| Dec 2021 | $192.78 M(+119.0%) | $67.46 M(+37.9%) |
| Sep 2021 | - | $48.90 M(+12.6%) |
| Jun 2021 | - | $43.43 M(+31.7%) |
| Mar 2021 | - | $32.98 M(+17.2%) |
| Dec 2020 | $88.03 M(+37.2%) | - |
| Dec 2020 | - | $28.13 M(+20.6%) |
| Sep 2020 | - | $23.34 M(+28.1%) |
| Jun 2020 | - | $18.22 M(-0.7%) |
| Mar 2020 | - | $18.34 M |
| Dec 2019 | $64.15 M | - |
FAQ
- What is Recursion Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual operating expenses year-on-year change?
- What is Recursion Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly operating expenses year-on-year change?
What is Recursion Pharmaceuticals annual total operating expenses?
The current annual operating expenses of RXRX is $351.35 M
What is the all time high annual operating expenses for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual total operating expenses is $351.35 M
What is Recursion Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, RXRX annual total operating expenses has changed by +$114.22 M (+48.17%)
What is Recursion Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of RXRX is $112.36 M
What is the all time high quarterly operating expenses for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly total operating expenses is $112.36 M
What is Recursion Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, RXRX quarterly total operating expenses has changed by +$13.69 M (+13.88%)